Orange Book product · Generic (ANDA)
LEVOLEUCOVORIN CALCIUM
LEVOLEUCOVORIN CALCIUM
At a glance
Oct 20, 2015
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 20, 2015
10 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
LEVOLEUCOVORIN CALCIUM
Strength
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
ANDA 203576
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LEVOLEUCOVORIN CALCIUM
- 2016LEVOLEUCOVORIN CALCIUMBrand (NDA)
NDA 208723 · ACTAVIS LLC
- 2008FUSILEVBrand (NDA)
NDA 020140 · ACROTECH BIOPHARMA
- 2023LEVOLEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 217314 · HAINAN POLY PHARM
- 2021LEVOLEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 213797 · PRAXGEN
- 2019LEVOLEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 211003 · MEITHEAL
- 2019LEVOLEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 211002 · MEITHEAL
- 2018LEVOLEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 210892 · GLAND
- 2018LEVOLEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 210623 · INGENUS PHARMS LLC
- 2017LEVOLEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 207548 · AMNEAL
- 2017LEVOLEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 206516 · ACTAVIS LLC
- 2017LEVOLEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 207547 · AMNEAL
- 2016LEVOLEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 206263 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
